- Home
- SNN vs ELAN Comparison
SNN vs ELAN Comparison
Compare SNN & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNN | ELAN |
|---|---|---|
| Founded | 1856 | 1954 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 12.2B |
| IPO Year | 2002 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SNN | ELAN |
|---|---|---|
| Price | $27.62 | $22.43 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $36.25 | $27.89 |
| AVG Volume (30 Days) | 1.7M | ★ 4.0M |
| Earning Date | 03-16-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.48% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $8.58 | $8.21 |
| Revenue Next Year | $5.60 | $5.31 |
| P/E Ratio | ★ $64.97 | $103.36 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $27.23 | $18.48 |
| 52 Week High | $37.51 | $27.98 |
Technical Indicators
Market Signals| Indicator | SNN | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 36.68 | 36.93 |
| Support Level | $27.23 | $21.89 |
| Resistance Level | $31.36 | $22.69 |
| Average True Range (ATR) | 0.53 | 0.71 |
| MACD | -0.02 | -0.14 |
| Stochastic Oscillator | 15.65 | 1.30 |
Price Performance
Historical ComparisonAbout SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.